Log In
Print
BCIQ
Print
Print this Print this
 

AV-203

  Manage Alerts
Collapse Summary General Information
Company Aveo Pharmaceuticals Inc.
DescriptionEpidermal growth factor receptor 3 (EGFR3; HER3; ErbB3) targeted antibody
Molecular Target Epidermal growth factor receptor 3 (EGFR3) (HER3) (ErbB3)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today